Speaker's Highlight

• Don Sin University of British Columbia, St. Paul Hospital (Canada)
  Kenneth R. Chapman Toronto General Hospital Research Institute (Canada)
• Parameswaran Nair McMaster University (Canada)
  Carolyn Calfee UCSF (U.S.A.)
• Gregory P. Downey University of Colorado School of Medicine (U.S.A.)
  David A. Schwartz University of Colorado School of Medicine (U.S.A.)
• Neil Schluger Tuberculosis Control Branch, California Department of Public Health (U.S.A.)
  Nick Kim Critical Care & Sleep Medicine, University of California San Diego (U.S.A.)
• Nicola Hananiah Baylor College of Medicine (U.S.A.)
  Jae-Joon Yim Seoul National University College of Medicine (Republic of Korea)
• Koichiro Asano Tokai University School of Medicine (Japan)
  Diahn-Warng Perng Taipei Veterans General Hospital (Taiwan)
• Konstantinos Kostikas University of Ioannina (Greece)
  Karin Klooster University Medical Center Groningen (Kingdom of the Netherlands)

• Understanding alveolar macrophages in lung defense

  Every breath delivers oxygen alongside dust, pollutants, microbes, and microscopic particles. Alveolar macrophages stand at this vulnerable boundary, patrolling the air sacs where gas exchange occurs. These long-lived immune cells help keep the lower respiratory tract clear while limiting unnecessary inflammation that could damage delicate lung tissue.

  Their role is more nuanced than simply destroying pathogens. Alveolar macrophages remove cellular debris, coordinate with epithelial cells, communicate with circulating immune cells, and adapt to local signals from the airway environment. Their activity must remain carefully balanced: too little response permits infection, while too much can impair breathing.

  Understanding this balance is central to respiratory medicine. It helps explain why the same immune mechanisms that protect the lungs can contribute to pneumonia, asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and severe viral infections.

  Where these immune cells work

  Alveolar macrophages reside on the surface of the alveoli, often extending processes between epithelial cells to sample the airspace. They develop under the influence of the lung environment and are replenished largely through local self-renewal, although recruited monocytes may supplement the population during injury or infection.

  Their position gives them early access to inhaled material. They ingest bacteria, fungi, dead cells, and fine particles through phagocytosis. After engulfment, intracellular compartments called phagolysosomes use enzymes, reactive molecules, and acidic conditions to break down much of this material.

  The lung also contains interstitial macrophages in the tissue between airways and blood vessels. These cells have distinct locations and functions, including regulation of inflammation and communication with nearby structural cells. Together, the macrophage populations form part of the pulmonary innate immune system.

  How they recognize threats

  Alveolar macrophages use pattern-recognition receptors to identify molecular signatures associated with microbes or tissue injury. Receptors such as Toll-like receptors and C-type lectin receptors detect bacterial components, viral nucleic acids, fungal structures, and other danger signals.

  Once activated, macrophages can release cytokines and chemokines that influence the wider immune response. Signals such as tumor necrosis factor, interleukins, and interferons help recruit neutrophils, natural killer cells, and lymphocytes when a stronger defense is needed. They can also present antigen fragments to adaptive immune cells, linking innate and adaptive immunity.

  Activation is shaped by the surrounding alveolar fluid, surfactant proteins, oxygen levels, and signals from epithelial cells. This context helps macrophages distinguish between harmless particles and threats that require escalation. Their behavior is therefore highly responsive rather than fixed.

  Clearing pathogens without harming the lung

  A healthy macrophage response removes invaders efficiently while preserving the thin alveolar barrier. Efferocytosis, the uptake of dying or damaged cells, is especially important after inflammation. By clearing these remnants, macrophages prevent cellular debris from becoming a continuing source of immune stimulation.

  Surfactant proteins also influence macrophage behavior. They support particle handling and help regulate inflammatory activity, allowing the lungs to remain immunologically alert without reacting intensely to every inhaled substance. This controlled state is sometimes described as pulmonary immune tolerance.

  The following comparison shows how macrophage activity may shift across common respiratory situations:

  Respiratory setting	Main macrophage activity	Potential benefit	Risk when dysregulated
  Healthy lung	Surveillance, debris removal, immune tolerance	Maintains clean alveoli and stable gas exchange	Reduced clearance can allow persistent irritants
  Bacterial pneumonia	Phagocytosis and inflammatory signaling	Restricts microbial growth and recruits support	Excess cytokines may injure alveolar tissue
  Viral infection	Recognition of infected cells and antiviral signaling	Coordinates early host defense	Prolonged inflammation may worsen respiratory failure
  Smoking or pollution exposure	Particle uptake and stress responses	Removes some inhaled material	Chronic activation can sustain tissue damage
  Fibrotic lung disease	Interaction with fibroblasts and repair pathways	Supports wound healing	Persistent profibrotic signaling may promote scarring

  The outcome depends on timing, pathogen type, genetic factors, and the condition of the host. A short, coordinated response can be protective, whereas unresolved activation may change macrophage metabolism and encourage chronic inflammation or abnormal repair.

  When protection becomes pathology

  In bacterial pneumonia, alveolar macrophages sense microbial structures and produce signals that recruit neutrophils. These recruited cells can rapidly kill bacteria, but their enzymes and oxidants may also damage the alveolar-capillary barrier. Macrophages help determine whether the response resolves or continues after the pathogen has been controlled.

  Respiratory viruses create a different challenge. Macrophages may detect viral material and release antiviral mediators, yet infected or activated cells can contribute to excessive cytokine production. In severe disease, this inflammatory amplification may increase alveolar permeability and interfere with oxygen exchange.

  Chronic exposure to cigarette smoke, biomass fuel, or air pollution can alter macrophage clearance and metabolism. Cells may become overloaded with particles, less effective at engulfing microbes, or persistently inflammatory. These changes are relevant to COPD, emphysema, and susceptibility to recurrent respiratory infections.

  Relevance to respiratory research and care

  Macrophage biology is increasingly studied through single-cell sequencing, imaging, bronchoalveolar lavage, and functional assays. These methods reveal diverse macrophage states rather than a simple division between “resting” and “activated” cells. Researchers are examining how age, sex, smoking history, infection, and treatment influence these states.

  This work may support more precise therapies. Potential approaches include modifying macrophage inflammatory signals, improving efferocytosis, restoring antimicrobial function, or influencing metabolic pathways that shape immune behavior. Any intervention must preserve essential host defense while avoiding excessive tissue injury.

  For clinicians and congress attendees reviewing current respiratory research, the detailed congress program provides useful context for how immunology connects with pulmonary infection, critical care, and broader lung-health discussions. Macrophages sit at the intersection of these fields because their activity affects both acute illness and long-term disease progression.

  Practical points for interpreting macrophage findings

  Macrophage studies should be interpreted with attention to the biological setting. Cells isolated from bronchoalveolar lavage may behave differently from those remaining in intact tissue, and findings from experimental models may not fully represent human disease.

  Important considerations include:

  • Distinguish resident alveolar macrophages from monocyte-derived cells recruited during inflammation.
  • Assess both antimicrobial activity and the capacity to resolve inflammation.
  • Consider how smoking, pollution, age, medication, and comorbidities alter macrophage function.
  • Interpret cytokine measurements alongside cellular behavior, tissue injury, and clinical outcomes.
  • Examine timing, because early defense and later repair involve different macrophage programs.

  A balanced view avoids labeling macrophages as universally beneficial or harmful. Their effects depend on location, timing, metabolic state, and communication with epithelial, endothelial, stromal, and adaptive immune cells.

  Alveolar macrophages are central guardians of the gas-exchange surface. They capture threats, remove debris, regulate inflammation, and help restore tissue after injury. Continued research into these adaptable immune cells can improve understanding of pneumonia, chronic airway disease, and inflammatory lung disorders. Explore the congress resources and respiratory medicine program to follow how this rapidly developing science informs future pulmonary care.

  Richard Russell Nuffield Department of Clinical Medicine, University of Oxford (United Kingdom)
• Mona Bafadhel King’s College London (United Kingdom)
  David Jackson Guy’s and St Thomas’ Hospital, King’s College London (United Kingdom)
• James Chalmers University of Dundee (United Kingdom)
  David Price University of Aberdeen (United Kingdom)